27 related articles for article (PubMed ID: 31571373)
1. The value of HPV E6/E7 mRNA quantitative analysis in distinguishing high-grade cervical squamous intraepithelial lesions from low-grade cervical squamous intraepithelial lesions.
Liu J; Yang T; Hu Y; Ye C
J Virol Methods; 2021 Mar; 289():114014. PubMed ID: 33188806
[TBL] [Abstract][Full Text] [Related]
2. Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion.
Mendoza LP; Arbiza J; Paez M; Kasamatsu E; Castro A; Giménez G; Basiletti J; Gonzalez J; Mongelós P; Picconi MA
J Med Virol; 2011 Aug; 83(8):1351-7. PubMed ID: 21618554
[TBL] [Abstract][Full Text] [Related]
3. Cervical Cancer as a Global Concern: Contributions of the Dual Epidemics of HPV and HIV.
Chibwesha CJ; Stringer JSA
JAMA; 2019 Oct; 322(16):1558-1560. PubMed ID: 31638658
[No Abstract] [Full Text] [Related]
4. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
5. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
[TBL] [Abstract][Full Text] [Related]
6. Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix.
Dabeski D; Duvlis S; Basheska N; Antovska V; Stojovski M; Trajanova M; Dimitrov G; Dabeski A; Gureva-Gjorgievska N
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):51-58. PubMed ID: 31152639
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus-induced lesions of the anogenital tract among women with vulvar high-grade squamous intraepithelial lesions.
Isnard C; Seta V; Cesbron E; Bergeron C; Chanal J; Aynaud O
J Am Acad Dermatol; 2021 Jun; 84(6):1749-1750. PubMed ID: 33011323
[No Abstract] [Full Text] [Related]
8. Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.
Bhuyan PK; Dallas M; Kraynyak K; Herring T; Morrow M; Boyer J; Duff S; Kim J; Weiner DB
Hum Vaccin Immunother; 2021 May; 17(5):1288-1293. PubMed ID: 33175656
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative human papillomavirus testing: earlier prediction of treatment failure.
McClymont E; Lee M
BJOG; 2020 Jan; 127(1):106. PubMed ID: 31571373
[No Abstract] [Full Text] [Related]
10. Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16
Kawashita S; Matsuda K; Kondo H; Kitajima Y; Hasegawa Y; Shimada T; Kitajima M; Miura K; Nakashima M; Masuzaki H
Cancer Control; 2020; 27(1):1073274819901170. PubMed ID: 32077330
[TBL] [Abstract][Full Text] [Related]
11. A case-control study of human papillomavirus and cervical squamous intraepithelial lesions (SIL) in Harris County, Texas: differences among racial/ethnic groups.
Tortolero-Luna G
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S207-8. PubMed ID: 16419209
[No Abstract] [Full Text] [Related]
12. Predictors of treatment failure after top-hat procedure in squamous intraepithelial lesion.
Chen X; Fan B; Jiang L; Nong L; Dong Y; Tao X
J Obstet Gynaecol Res; 2021 Feb; 47(2):661-668. PubMed ID: 33217141
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities.
Burger MP; Hollema H; Pieters WJ; Quint WG
BMJ; 1995 Jan; 310(6972):94-5. PubMed ID: 7833734
[No Abstract] [Full Text] [Related]
14. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.
Aromseree S; Chaiwongkot A; Ekalaksananan T; Kongyingyoes B; Patarapadungkit N; Pientong C
J Med Virol; 2014 Nov; 86(11):1911-9. PubMed ID: 25091234
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
